Explore more publications!

North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

Press releases published on January 19, 2026

Canadian Association of Occupational Therapy and Speech-Language & Audiology Canada Call for Action as Delays Under Jordan’s Principle and the Inuit Child First Initiative Deny First Nations and Inuit Children Access to Essential Care
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
Valneva fait un point sur son vaccin contre le chikungunya IXCHIQ®
Metabo Drops 2026 [Latest Update]: Is It Legit? Liquid Delivery Science, Ingredient Research, and Informed Consumer Analysis
Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
Advancing Quality of Life for Deaf and Hard of Hearing Communities: Canadian Hearing Services Awards Four New Research Grants
Améliorer la qualité de vie pour les communautés des Sourds et des malentendants : les Services Canadiens de l’Ouïe attribuent quatre nouvelles subventions de recherche
BVI Appoints Jim Hollingshead as President & Chief Executive Officer
Kaléo Strengthens Leadership Team to Advance Drug Delivery and Autoinjector Innovation
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
CUKTECH Launches 30 Ultra Charging Station in Malaysia, Redefining the Desktop Charging Experience
CUKTECH Melancarkan Stesen Pengecasan 30 Ultra di Malaysia, Mentakrifkan Semula Pengalaman Pengecasan Desktop
Biotin and Collagen Supplement Formats in 2026: NUTRAHARMONY Releases New Consumer Research
Blockchain Technology in Healthcare Market to Reach USD 345.89 Billion by 2032 at 63.90% CAGR, Driven by Rising Demand for Privacy Compliance: AnalystView Market Insights
Immuron Reports Continued Sales Growth
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
Concept Life Sciences Appoints Dr Adam Davenport as CSO to Strengthen Leadership in Integrated Drug Discovery
FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions